Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cellsReportar como inadecuado

Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Cancer Cell International

, 13:24

First Online: 12 March 2013Received: 12 February 2013Accepted: 08 March 2013


Pediatric acute myeloid leukemia AML is a heterogeneous disease and remains clinically challenging. Currently chemotherapies are frequently associated with treatment-related death and long-term side effects. Therefore, alternative approaches with lower toxicity are highly desired. Ginsenosides and metabolites are the main ingredients responsible for the multiple pharmaceutical functions of ginseng, which is one of the most commonly consumed herbal medicines world widely. In the present study, we demonstrated that compound K, a major ginsenoside metabolite, inhibited the growth of the clinically relevant pediatric AML cell lines in a time- and dose-dependent manner. This growth inhibitory effect was attributable to suppression of DNA synthesis during cell proliferation. Furthermore, we observed significant G1 cell cycle arrest and apoptosis induced by compound K. The induction of apoptosis was accompanied by DNA double strand breaks. Our findings suggest that as a low toxic natural reagent, compound K could be a potential drug for pediatric AML intervention and to improve the outcome of pediatric AML treatment.

KeywordsGinsenoside Compound K Pediatric acute myeloid leukemia Electronic supplementary materialThe online version of this article doi:10.1186-1475-2867-13-24 contains supplementary material, which is available to authorized users.

Download fulltext PDF

Autor: Yan Chen - Yajing Xu - Yan Zhu - Xiaolin Li


Documentos relacionados